Finn Scope
Search companies, stocks, cryptocurrencies, and more...
Markets
Stocks
Crypto
Forex
Commodities
dark
light
Overview
Financial Statement
Ratio
Dividend
Net Worth
Financial Forecast
Operating Data
Free Cash Flow
Balance Sheet
EPS
Revenue
Stock Splits
Aptose Biosciences Inc.
APTO | NASDAQ Capital Market
0.279
USD
0.1088 %
Discover Aptose Biosciences Inc.'s operating metrics, offering insights into performance and future trends.
Breakdown
2028
2027
2026
2025
2024
2023
2022
2021
2020
2019
Revenue
0
0
0
0
0
0
0
0
0
0
Revenue %
0
0
0
0
0
0
0
0
0
0
Ebitda
0
0
0
0
0
-52.27 M
%31.79
-39.66 M
%-38.19
-64.16 M
%11.57
-57.51 M
%119.00
-26.26 M
Ebitda %
100
%0.00
100
%0.00
100
%0.00
100
%0.00
100
%0.00
100
%0.00
100
%0.00
100
%0.00
100
%0.00
100
Ebit
0
0
0
0
0
-52.36 M
%30.35
-40.17 M
%-38.00
-64.78 M
%11.39
-58.16 M
%116.29
-26.89 M
Ebit %
100
%0.00
100
%0.00
100
%0.00
100
%0.00
100
%0.00
100
%0.00
100
%0.00
100
%0.00
100
%0.00
100
Depreciation
0
0
0
0
0
88 K
%-82.65
507.08 K
%-17.75
616.53 K
%-4.63
646.43 K
%3.06
627.25 K
Depreciation %
100
%0.00
100
%0.00
100
%0.00
100
%0.00
100
%0.00
100
%0.00
100
%0.00
100
%0.00
100
%0.00
100
Chart
Historical Data
Income Statement
Balance Sheets
Cash Flows
Analysis Rates
Evaluation Rates
P/B Ratio
P/S Ratio
P/E Ratio
P-FCF Ratio
Dividends Yield
Dividends Payments
Total Assets
Total Liabilities
Operating Data
Free Cash Flow
Balance Sheet
EPS
Revenue
Stock Splits